NCT00000244View on ClinicalTrials.gov

Effects of Dynorphin 1-13 on Heroin Addiction - 1

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

August 31, 1994

Primary Completion Date

March 31, 1997

Study Completion Date

March 31, 1997

Conditions
Opioid-Related DisordersSubstance Withdrawal Syndrome
Interventions
DRUG

Dynorphin 1 - 13

Trial Locations (1)

55415

U of Minnesota School of Medicine, Minneapolis

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Minnesota

OTHER

NCT00000244 - Effects of Dynorphin 1-13 on Heroin Addiction - 1 | Biotech Hunter | Biotech Hunter